Skip to main content
$65.48 -$1.22 (-1.8%)

04:00 PM EST on 01/27/21

Gilead Sciences, Inc. (NASDAQ:GILD)

CAPS Rating: 4 out of 5

A biopharmaceutical company that discovers, develops and commercializes innovative therapeutics in areas of unmet medical need.

Current Price $65.48 Mkt Cap $82.1B
Open $65.75 P/E Ratio 65.04
Prev. Close $65.48 Div. (Yield) $2.72 (4.2%)
Daily Range $65.08 - $66.92 Volume 5,115
52-Wk Range $56.56 - $85.97 Avg. Daily Vol. 9,766,826

Caps

How do you think NASDAQ:GILD will perform against the market?

Add Stock to CAPS Watchlist

All Players

3,377 Outperform
89 Underperform
 

All-Star Players

664 Outperform
10 Underperform
 

Wall Street

0 Outperform
0 Underperform
 

Top NASDAQ:GILD Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

blakeman1000 (60.88)
Submitted February 17, 2017

This company has proved that it can cure diseases. It has over $30B in cash. Good mgmt. Good yield. As of today at has a P/E of 7. If this company was not here tomorrow, people would notice.

CMFTomato (98.84)
Submitted September 04, 2020

I have a real hard time imagining that Gilead will have sold enough Remdesivir to make this stock a market performer much less a market *beater.* I do continue to own shares in my real portfolio though, so I'm happy to be proven wrong. Underperform.

Recent Community Commentary

Read the most recent pitches from players about GILD.

Recs

0
Member Avatar Dividends500 (78.22) Submitted: 12/31/2020 11:37:12 PM : Outperform Start Price: $58.67 NASDAQ:GILD Score: +11.85

Dividends500 tracks the healthiest dividends in the S&P 500.

To qualify for the portfolio, the company must meet three simple requirements:

- Member of the S&P 500
- Payout ratio below 50%
- Dividend growth year over year

Recs

0
Member Avatar dusand (92.03) Submitted: 12/11/2020 1:46:33 PM : Outperform Start Price: $59.98 NASDAQ:GILD Score: +6.68

Looks cheap. This company has several projects with positive surprise potential. Also, the stock price fell to a level where it becomes a value pick.

Recs

0
Member Avatar TMFjbonefish (60.21) Submitted: 11/23/2020 12:46:07 PM : Underperform Start Price: $58.89 NASDAQ:GILD Score: -6.15

More data on Remdesivir likely to show it's not very effective; A new administration will undo FDA approval if liver and kidney side effects persist. Increasingly desperate acquisitions at extreme valuations will be hard to generate a return. Finally, the US government is going to take profits or patents related to HIV and hepatitis -- I don't see a way around that severely limiting the company's profit moving forward.

Leaderboard

Find the members with the highest scoring picks in GILD.

Score Leader

BrianMotleyFool

BrianMotleyFool (70.13) Score: +536.73

The Score Leader is the player with the highest score across all their picks in GILD.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
WilliamCrook2003 71.49 1/29/2007 1/25/2012 Outperform 5Y $13.27 +393.51% +179.49% +214.02 1 Comment
UrineLuck73 < 20 1/29/2007 Outperform NS $13.27 +393.51% +179.49% +214.02 0 Comment
JSergeant 73.39 7/3/2006 Outperform 3Y $12.57 +421.13% +213.01% +208.12 0 Comment
predragj 40.31 1/30/2007 Outperform NS $13.44 +387.26% +179.17% +208.09 0 Comment
mxdfool < 20 12/15/2006 Outperform 5Y $13.50 +385.04% +178.21% +206.83 0 Comment
betsypurcell < 20 1/24/2007 Outperform NS $13.52 +384.37% +177.97% +206.40 0 Comment
rmarinchek < 20 1/25/2007 Outperform 3W $13.62 +380.74% +176.28% +204.46 0 Comment
Redskins2k9 < 20 1/25/2007 Outperform 5Y $13.62 +380.74% +176.28% +204.46 0 Comment
opveiby 77.96 1/25/2007 Outperform 5Y $13.62 +380.74% +176.28% +204.46 0 Comment
jer8899 70.12 1/23/2007 Outperform NS $13.59 +381.79% +178.00% +203.79 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for GILD.